BIIB
Biogen Inc.
BIIB
Key terms
About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BIIB news
Apr 26 7:58am ET Sage Therapeutics price target lowered to $15 from $26 at RBC Capital by TipRanks Apr 26 5:50am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Dexcom (DXCM) and Herbalife (HLF) by TipRanks Apr 26 2:22am ET Buy Rating Justified: Biogen’s Promising Drug Launches and Strategic Growth Initiatives by TipRanks Apr 26 2:09am ET Biogen’s Surpassing Performance and Positive Outlook Affirm Buy Rating by TipRanks Apr 26 1:58am ET Biogen’s Financial Upswing: Strong Q1 Performance and Market Penetration Justify Buy Rating by TipRanks Apr 25 4:45pm ET Biogen announces CHMP opinion recommending Tofidence by TipRanks Apr 25 4:44pm ET Biogen receives positive CHMP opinion for TOFIDENCE by TipRanks Apr 25 2:16pm ET Sage Therapeutics price target lowered to $18 from $22 at Truist by TipRanks Apr 25 8:28am ET Biogen price target raised to $215 from $213 at Wedbush by TipRanks Apr 25 7:56am ET Jefferies Keeps Their Buy Rating on Biogen (BIIB) by TipRanks Apr 25 7:32am ET Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Universal Health (UHS) by TipRanks Apr 25 7:28am ET Biogen price target lowered to $250 from $260 at BofA by TipRanks Apr 25 7:10am ET Truist Financial Reaffirms Their Buy Rating on Biogen (BIIB) by TipRanks Apr 25 7:02am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Evolent Health (EVH) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 25 6:58am ET Biogen price target raised to $308 from $305 at Canaccord by TipRanks Apr 25 5:40am ET Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Biogen (BIIB) and Molina Healthcare (MOH) by TipRanks Apr 25 4:58am ET Biogen price target lowered to $200 from $215 at Barclays by TipRanks Apr 24 9:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB) by TipRanks Apr 24 8:00am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 24 6:50am ET Biogen backs FY24 adjusted EPS view of $15.00-$16.00, consensus $15.46 by TipRanks Apr 24 6:48am ET Biogen reports Q1 adjusted EPS $3.67, consensus $3.44 by TipRanks Apr 24 5:42am ET Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Biogen (BIIB) and Neurocrine (NBIX) by TipRanks Apr 24 5:28am ET QQQ ETF Update, 4/24/2024 by TipRanks Apr 23 8:25pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 23 1:18pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 23 5:19am ET QQQ ETF Update, 4/23/2024 by TipRanks Apr 22 8:28am ET Piper Sandler Sticks to Its Buy Rating for Biogen (BIIB) by TipRanks Apr 19 7:50am ET Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) by TipRanks Apr 19 7:43am ET Biogen price target lowered to $270 from $290 at Oppenheimer by TipRanks Apr 17 6:52am ET QQQ ETF Update, 4/17/2024 by TipRanks Apr 15 6:29am ET QQQ ETF Update, 4/15/2024 by TipRanks
No recent press releases are available for BIIB
BIIB Financials
1-year income & revenue
Key terms
Ad Feedback
BIIB Forecasts
analyst rating
- buy
- hold
- sell
We're sorry, but this
information is
temporarily unavailable.
1-year stock price forecast
BIIB Competitors
$ Market cap P/E ratio $ Price 1d change 52-week range
